3,6-Di-tert-butyl-9-(2-(dicyclohexylphosphino)phenyl)-9H-carbazole

Catalog No. :
ACPVMW239
CAS No. :
1888463-32-8
Molecular Formula :
C38H50NP
Molecular Weight :
551.80

IUPAC Name:3,6-di-tert-butyl-9-(2-(dicyclohexylphosphaneyl)phenyl)-9H-carbazole

3,6-Di-tert-butyl-9-(2-(dicyclohexylphosphino)phenyl)-9H-carbazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3,6-Di-tert-butyl-9-(2-(dicyclohexylphosphino)phenyl)-9H-carbazole
IUPAC Name3,6-di-tert-butyl-9-(2-(dicyclohexylphosphaneyl)phenyl)-9H-carbazole
MDL No.-
Molecular FormulaC38H50NP
Molecular Weight551.80
SMILESCC(C1=CC2=C(N(C3=CC=CC=C3P(C4CCCCC4)C5CCCCC5)C6=C2C=C(C(C)(C)C)C=C6)C=C1)(C)C
InChI KeyYYANURIZGQIBQZ-UHFFFAOYSA-N
Synonym9H-Carbazole, 9-[2-(dicyclohexylphosphino)phenyl]-3,6-bis(1,1-dimethylethyl)-;3,6-Di-tert-butyl-9-[2-(dicyclohexylphosphino)phenyl]-9H-carbazole
CAS No.1888463-32-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACPVMW239 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLUAN743 route compound structure diagram
    ACLUAN74337500-95-1 In Stock
  4. Then
  5. ACPVMW239 route product structure diagram
    ACPVMW2391888463-32-8
Inquiry

2. ACPVMW239 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLUAN743 route compound structure diagram
    ACLUAN74337500-95-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPVMW239 route product structure diagram
    ACPVMW2391888463-32-8
Inquiry

Comments (0)